News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,193 Results
Type
Article (13619)
Company Profile (108)
Press Release (248466)
Section
Business (87961)
Career Advice (464)
Deals (15328)
Drug Delivery (64)
Drug Development (36549)
Employer Resources (49)
FDA (6264)
Job Trends (6189)
News (150067)
Policy (14015)
Tag
Academia (435)
Alliances (23140)
Alzheimer's disease (363)
Approvals (6275)
Artificial intelligence (66)
Bankruptcy (144)
Best Places to Work (4349)
Breast cancer (61)
Cancer (410)
Career advice (406)
Cell therapy (57)
Clinical research (30566)
Collaboration (197)
Compensation (83)
COVID-19 (748)
C-suite (58)
Data (428)
Diabetes (64)
Diagnostics (1242)
Drug discovery (43)
Drug pricing (59)
Earnings (31590)
Employer resources (43)
Events (36908)
Executive appointments (219)
FDA (6503)
Funding (132)
Gene therapy (63)
GLP-1 (303)
Government (1271)
Healthcare (3533)
Infectious disease (768)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5837)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3414)
Lung cancer (57)
Manufacturing (110)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9568)
Metabolic disorders (193)
Neuroscience (474)
NextGen Class of 2024 (1580)
Non-profit (591)
Northern California (498)
Obesity (113)
Opinion (112)
Patents (65)
People (28554)
Pharmaceutical (67)
Phase I (7954)
Phase II (12929)
Phase III (11611)
Pipeline (197)
Policy (46)
Postmarket research (1400)
Preclinical (3178)
Radiopharmaceuticals (116)
Rare diseases (109)
Real estate (2629)
Regulatory (9895)
Research institute (563)
Resumes & cover letters (55)
Southern California (491)
Startups (1626)
United States (4909)
Vaccines (114)
Weight loss (83)
Date
Last 7 days (59)
Last 30 days (572)
Last 365 days (12246)
2025 (34)
2024 (12509)
2023 (14248)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11714)
2017 (13892)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (43)
Asia (19884)
Australia (2567)
California (1168)
Canada (678)
China (146)
Colorado (46)
Connecticut (48)
Europe (38922)
Florida (190)
Illinois (136)
Indiana (97)
Japan (54)
Kansas (52)
Maryland (175)
Massachusetts (1002)
Minnesota (65)
New Jersey (504)
New York (327)
North Carolina (293)
Northern California (498)
Pennsylvania (319)
South America (499)
Southern California (491)
Texas (161)
Virginia (46)
Washington State (79)
262,193 Results for "mithra pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mithra postpones its annual general meeting
Mithra, a company dedicated to women’s health, announces that in the context of the monetization process and the uncertainties related thereto, Mithra postpones its Annual General Shareholders’ Meeting, previously planned for 30 May 2024, to a later date to be determined.
May 28, 2024
·
3 min read
Mithra updates on cash position - February 06, 2024
Mithra, a company dedicated to women’s health, provides an update on its current cash position and its plans to address its runway and creating and optimizing value for all its stakeholders.
February 6, 2024
·
4 min read
Mithra’s NEXTSTELLIS® granted additional patent in the United States
Mithra, a company dedicated to Women’s Health, announces that it has been granted an additional patent for NEXTSTELLIS® tablets) in the United States.
November 7, 2023
·
4 min read
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces the completion of a pediatric study of its marketed contraceptive ESTELLE® in adolescent women.
December 20, 2023
·
4 min read
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel
Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces the signing of a binding Head of Terms (HoT) agreement for the commercialization of DONESTA® in Israel with Rafa Laboratories LTD, an Israeli pharmaceutical company.
December 21, 2023
·
4 min read
Business
Mithra and Searchlight Pharma Sign DONESTA® Licensing Agreement for Canada
Mithra and Searchlight Pharma Sign DONESTA ® Licensing Agreement for Canada.
October 26, 2023
·
6 min read
Policy
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
Mithra announces that the US Food and Drug Administration has provided feedback regarding its new drug application marketing authorization filing in the United States.
November 30, 2023
·
7 min read
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
Mithra announced the signing of a binding term sheet for a licensing agreement for the Canadian rights to Donesta®, an investigational medicine for the treatment of the symptoms of menopause.
July 31, 2023
·
6 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent
Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA are pleased to announce NEXTSTELLIS® has been nominated for the 2022 Prix Galien USA Award for Best Pharmaceutical Agent.
August 2, 2022
·
4 min read
1 of 26,220
Next
